A43-53596-52235
4 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 276 / NC
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
BSB-27194-87618
Child or adolescent in my care · Male · 2022-06-29
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-10
Registered in v-safe
- 2021-01-10
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-04-12
- 2021-07-12
-
2021-10-15
Dose 3 — Pfizer-BioNTech
- 2022-01-11
- 2022-04-20
-
2022-09-22
Dose 4 — Pfizer-BioNTech
- 2022-10-10
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
-
2022-12-22
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Free text
Release 12 — 3 months, dose 4
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release